CTU: 177Lu-TLX250-001 Phase 1b Dose Escalation/Expansion Study of the Combination of 177Lu-TLX250 and Peposertib in Patients with Carbonic Anhydrase IX (CAIX)-Expressing Solid Tumors

  • Gurney, Howard (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Contacos, Christine (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Keshiya, Shikara (Clinical Trial Unit Staff)

Project: Research

Project Details

Short title177Lu-TLX250-001
StatusActive
Effective start/end date29/06/23 → 28/06/28